A pharma company used curated single-cell data on Polly to speed target identification in inflammatory disease.

The company needed to accelerate target discovery and validation for inflammatory disease using single-cell RNA-seq data. Elucidata used curated data on Polly and its single-cell analysis expertise. The page reports 4 new targets identified, 5 pre-identified targets validated and 4x faster identification and validation.

Elucidata is a biomedical data company whose Polly platform harmonizes and curates omics and clinical data for AI-driven target discovery.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.